Chronic Urticaria: Optimizing Treatment in Challenging Cases

Allergy/ Immunology
Curriculum:
Chronic Urticaria: Optimizing Treatment in Challenging Cases
Credits:
1 AMA PRA Category 1 Credit(s)™
Launch Date:
September 26, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

immunologists, allergists, dermatology

Relevant Terms:

Urticaria, Chronic Urticaria, CU, CIU,

Richard G. Gower, MD, FACAAI, FAAAAI, FACP

Richard G. Gower, MD, FACAAI, FAAAAI, FACP
Allergist/Immunologist
Marycliff Allergy Specialists
Clinical Associate Professor of Medicine
University of Washington School of Medicine
Principal Investigator
Marycliff Allergy and Asthma Research
Premier Clinical Research
Spokane, Washington

 
Richard G. Gower, MD, FACAAI, FAAAAI, FACP, is a practicing allergist/immunologist at Marycliff Allergy Specialists in Spokane, Washington. He is Clinical Associate Professor of Medicine at the University of Washington School of Medicine and on the staff of Sacred Heart Medical Center and Deaconess Medical Center in Spokane. He is past president of the American College of Allergy, Asthma and Immunology, and a fellow of the American College of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the American College of Physicians.
 
After receiving his medical degree from the University of Colorado School of Medicine in Denver, Dr. Gower did a residency in internal medicine at the University of Miami Affiliated Hospitals in Miami, Florida. He then completed a fellowship in allergy/clinical immunology and vasculitis at the University of Colorado Medical Center in Denver.
 
He has been primary investigator in over 130 clinical studies on the treatment of asthma, allergic rhinitis/conjunctivitis, sinusitis, chronic urticaria, bronchitis, chronic obstructive pulmonary disease, and hereditary angioedema (HAE). Dr. Gower has presented papers at national and international meetings concerning diseases of the respiratory tract as well as HAE, and is the author of several publications.
 
Dr. Gower is also past president of the Intermountain West Allergy Association (IWAA), Western Society of Allergy, Asthma and Immunology, and Washington State Society of Internal Medicine, and is a member of numerous professional societies. In 2013, Dr. Gower was awarded the ACAAI Distinguished Fellow Award. He is past chair of the ACAAI Public Awareness and Education Campaign. A major goal of this national campaign is to educate the public about allergies and asthma. Dr. Gower addressed these important issues on Capitol Hill at a national level for years.
 
Recently Dr. Gower has been an author of several publications regarding hereditary angioedema, including a WAO position paper, and has participated in many HAE education sessions.
 
1. Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic urticaria (CU) taking into account the potential differential diagnosis
2. Incorporate into practice evidence-based treatment options and guidelines for managing CU that maximize clinical outcomes while minimizing adverse effects

ACCREDITATION & CREDIT
PHYSICIAN CONTINUING EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Estimated time to complete: 1 hour
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.
 
COMMERCIAL SUPPORT
This activity is jointly provided by RMEI, LLC and Postgraduate Institute for Medicine and is supported by an independent educational grant from Genentech.
 
DISCLOSURES & DISCLAIMER
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
 
Faculty Disclosures
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
  • Richard G. Gower, MD, has affiliations with CSL Behring, Dey, Dyax, Genentech, Novartis, Roche, Shire-ViroPharma, and Teva (Advisory/DSMB/Speaker); Anacor, AstraZeneca, CSL Behring, Circassia, Dey, Genentech, GlaxoSmithKline, Mylan, Novartis, Pharming, Roche, Shire-ViroPharma, and Teva (Research); Merck (Stocks).
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

RMEI, LLC
  • Lora Rhodes, MSW, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests to disclose.
  • Cynthia M. Kunzer, CMP, has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount
during the past 12 months.

Disclosure of Unlabled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
  • Physicians who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 75% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above